ACCELERATE NEWCO LIMITED

17037453
Active Newcastle

Manufacture of pharmaceutical preparations

Manufacture of pharmaceutical preparations
A

ACCELERATE NEWCO LIMITED

17037453

Manufacture of pharmaceutical preparations

Founded 17 Feb 2026 Active Newcastle, United Kingdom website.com
Manufacture of pharmaceutical preparations
Accounts
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

Stephenson Building The Science Park University Of Keele, Keele Newcastle ST5 5SP United Kingdom

Full company profile for ACCELERATE NEWCO LIMITED (17037453), an active company based in Newcastle, United Kingdom. Incorporated 17 Feb 2026. Manufacture of pharmaceutical preparations. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 139,114,617 Shares £13.91m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 Feb 2026139,114,617£13.91m£0.1

Officers

Officers

1 active 2 resigned
Status
Lipkin, Nathan IsaacDirectorAmericanUnited States356 May 2026Active

Shareholders

Shareholders (1)

Charles River Discovery Research Services Uk Limited
100.0%
100

Persons with Significant Control

Persons with Significant Control (3)

3 Active 1 Ceased
Notified 24 Feb 2026
Nature of Control
  • Ownership Of Shares 75 To 100 Percent
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors
Notified 24 Feb 2026
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Gi Accelerate Midco Limited

Unknown

Active
Notified 6 May 2026
Nature of Control
  • Voting Rights 75 To 100 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

ACCELERATE NEWCO LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
21 Jun 2026IncorporationMemorandum Articles
8 Jun 2026ResolutionResolutions
28 May 2026OfficersAppointment of Mr Jonathan Howard Goldman as director on 19 May 2026
28 May 2026OfficersTermination of David Anthony Smolen as director on 19 May 2026
26 May 2026Persons With Significant ControlChange to Charles River Laboratories England Limited as a person with significant control on 6 May 2026
21 Jun 2026 Incorporation

Memorandum Articles

8 Jun 2026 Resolution

Resolutions

28 May 2026 Officers

Appointment of Mr Jonathan Howard Goldman as director on 19 May 2026

28 May 2026 Officers

Termination of David Anthony Smolen as director on 19 May 2026

26 May 2026 Persons With Significant Control

Change to Charles River Laboratories England Limited as a person with significant control on 6 May 2026

Recent Activity

Latest Activity

Memorandum Articles

6 days ago on 21 Jun 2026

Resolutions

2 weeks ago on 8 Jun 2026

Appointment of Mr Jonathan Howard Goldman as director on 19 May 2026

1 months ago on 28 May 2026

Termination of David Anthony Smolen as director on 19 May 2026

1 months ago on 28 May 2026

Change to Charles River Laboratories England Limited as a person with significant control on 6 May 2026

1 months ago on 26 May 2026